Biochemical comparison of four commercially available C1 esterase inhibitor concentrates for treatment of hereditary angioedema
about
Recombinant replacement therapy for hereditary angioedema due to C1 inhibitor deficiencyApplying complement therapeutics to rare diseases.Plasma-derived C1-INH for managing hereditary angioedema in pediatric patients: A systematic review.Preventing Hereditary Angioedema Attacks in Children Using Cinryze®: Interim Efficacy and Safety Phase 3 Findings.
P2860
Biochemical comparison of four commercially available C1 esterase inhibitor concentrates for treatment of hereditary angioedema
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Biochemical comparison of four ...... tment of hereditary angioedema
@ast
Biochemical comparison of four ...... tment of hereditary angioedema
@en
type
label
Biochemical comparison of four ...... tment of hereditary angioedema
@ast
Biochemical comparison of four ...... tment of hereditary angioedema
@en
prefLabel
Biochemical comparison of four ...... tment of hereditary angioedema
@ast
Biochemical comparison of four ...... tment of hereditary angioedema
@en
P2093
P2860
P356
P1433
P1476
Biochemical comparison of four ...... tment of hereditary angioedema
@en
P2093
Annette Feussner
Georg Henkel
Peter Hofmann
Thomas Machnig
Uwe Kalina
P2860
P304
P356
10.1111/TRF.12678
P577
2014-05-08T00:00:00Z